Overview

An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma

Status:
Withdrawn
Trial end date:
2023-10-18
Target enrollment:
Participant gender:
Summary
An open label, single-arm clinical study evaluating the safety and efficacy of ICI201 infusion in relapsed/refractory multiple myeloma
Phase:
Phase 1
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University